While the controversy − and legal battles − heat up over New Jersey's affordable housing mandate, an explosion of ...

The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...